Summary

Middle East and Africa veterinary medicine market is expected to reach USD 5,150,189.52 thousand by 2032 from USD 2,866,471.26 thousand in 2024, growing at a CAGR of 7.6% in the forecast period of 2025 to 2032.
Market Segmentation:
Middle East and Africa Veterinary Medicine Market, By Type (Therapeutics and Diagnostics), Application (Bacterial Diseases, Canine Atopic Dermatitis, Heminthes Infection, Animal Cancer, Foot and Mouth Disease, Autoimmune Diseases, Bluetongue, and Others), Animal Type (Companion Animals and Production Animal), End User (Veterinary Hospitals, Veterinary Clinics, Animal And Veterinary Farms, Reference Laboratories, Academic And Research Institute, Point-Of-Care Testing/In-House Testing, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and Rest of Middle East and Africa) - Industry Trends & Forecast To 2032
Overview of the Middle East and Africa Veterinary Medicine Market are:

Driver

• Increasing Pet Ownership Boosts Demand For Veterinary Services

Restraint

• High Veterinary Care Costs Limit Market Accessibility

Opportunity

• Increasing Number of Animals Leading to The Demand of Veterinary Medicine

Market Players:

Some of the major players operating in the Middle East and Africa veterinary medicine market are:

• Zoetis Services LLC
• Merck & Co., Inc.
• Elanco or its affiliates
• C.H. Boehringer Ingelheim International GmbH
• IDEXX LABORATORIES, INC
• AB Science
• AdvaCare Pharma
• ALMAX IMAGING srl
• Anivive
• BIOMÉRIEUX
• Bionote USA Inc.
• Bio-Rad Laboratories, Inc.
• CANON MEDICAL SYSTEMS EUROPE B.V.
• Cargill, Incorporated
• Ceva
• CureLab Oncology
• Dechra Pharmaceuticals Limited
• Narang Medical Limited
• Neogen Corporation
• NIPPON ZENYAKU KOGYO CO., LTD.
• Demeditec Diagnostics GmbH
• DHN International
• Diagnostic Imaging Systems
• ESAOTE SPA
• Eurofins Scientific
• Evonik Industries AG
• FUJIFILM Holdings Corporation
• Gold Standard Diagnostics
• Hallmarq Veterinary Imaging
• Hebei Veyong Pharmaceutical Co., Ltd.
• IBIS S.R.L.
• Virbac
• VMRD, Inc.
• Heska Corporation
• Karyopharm
• Meridian Bioscience, Inc.
• VetDC
• Novavive Inc.
• Nutreco
• PLANMECA OΥ
• Randox Laboratories Ltd.
• RINGPU BIOLOGY Co., Ltd.
• Shenzhen SONT U Medical Imaging Equipment Co., Ltd
• Torigen Pharmaceuticals Inc.
• Thermo Fisher Scientific Inc.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 169
1.1 OBJECTIVES OF THE STUDY 169
1.2 MARKET DEFINITION 169
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET 169
1.4 CURRENCY AND PRICING 172
1.5 LIMITATIONS 172
1.6 MARKETS COVERED 172
2 MARKET SEGMENTATION 180
2.1 MARKETS COVERED 180
2.2 GEOGRAPHICAL SCOPE 181
2.3 YEARS CONSIDERED FOR THE STUDY 182
2.4 DBMR TRIPOD DATA VALIDATION MODEL 183
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 186
2.6 MULTIVARIATE MODELLING 187
2.7 DBMR MARKET POSITION GRID 188
2.8 MARKET END USER COVERAGE GRID 189
2.9 VENDOR SHARE ANALYSIS 190
2.10 SECONDARY SOURCES 191
2.11 ASSUMPTIONS 191
3 EXECUTIVE SUMMARY 192
4 PREMIUM INSIGHTS 201
4.1 PESTAL ANALYSIS 203
4.2 PORTERS FIVE FORCES ANALYSIS 204
4.3 PIPELINE ANALYSIS 205
4.4 TOP ENTITIES BASED ON R&D GLANCE FOR VETERINARY MEDICINE MARKET 206
4.5 EPIDEMIOLOGY 207
5 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET: REGULATIONS 208
6 MARKET OVERVIEW 210
6.1 DRIVERS 212
6.1.1 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES 212
6.1.2 RISING ANIMAL DISEASES DRIVE NEED FOR ADVANCED VETERINARY CARE 213
6.1.3 VETERINARY MEDICINE ADVANCES IMPROVE DIAGNOSIS AND TREATMENT OPTIONS 213
6.1.4 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS INCREASES VETERINARY NEEDS 214
6.2 RESTRAINTS 216
6.2.1 HIGH VETERINARY CARE COSTS LIMIT MARKET ACCESSIBILITY 216
6.2.2 LACK OF AWARENESS ABOUT ANIMAL HEALTH LIMITS PROPER VETERINARY CARE ACCESS 216
6.3 OPPORTUNITIES 218
6.3.1 INCREASING NUMBER OF ANIMALS LEADING TO THE DEMAND OF VETERINARY MEDICINE 218
6.3.2 GROWTH IN ANIMAL HEALTH BIOTECHNOLOGY 218
6.3.3 GROWTH IN DEMAND FOR NUTRITIONAL SUPPLEMENTS 219
6.4 CHALLENGES 220
6.4.1 CHALLENGES OF REGULATORY COMPLIANCE AND COMPLEXITY 220
6.4.2 SHORTAGE OF VETERINARY PROFESSIONALS 220
7 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY TYPE 222
7.1 OVERVIEW 223
7.2 THERAPEUTICS 226
7.2.1 PHARMACEUTICALS 228
7.2.1.1 ANTIBIOTICS 229
7.2.1.1.1 TETRACYCLINE 229
7.2.1.1.2 PENICILLINS 229
7.2.1.1.3 MACROLIDES 229
7.2.1.1.4 AMINOGLYCOSIDES 229
7.2.1.1.5 LINCOSAMIDES 229
7.2.1.1.6 COLISTIN 229
7.2.1.1.7 OTHERS 229
7.2.1.2 PARASITICIDES 230
7.2.1.2.1 BENZIMIDAZOLES 230
7.2.1.2.2 MACROCYCLIC LACTONES 230
7.2.1.2.3 PYRETHROIDS 230
7.2.1.2.4 AMPROLIUM 230
7.2.1.2.5 NITROIMIDAZOLES 230
7.2.1.2.6 PIPERAZINE 230
7.2.1.2.7 OTHERS 230
7.2.1.3 ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) 231
7.2.1.3.1 CARPROFEN 231
7.2.1.3.2 MELOXICAM 231
7.2.1.3.3 PHENYLBUTAZONE 231
7.2.1.3.4 ACETAMINOPHEN 231
7.2.1.3.5 FIROCOXIB 231
7.2.1.3.6 DERACOXIB 231
7.2.1.3.7 OTHERS 231
7.2.1.4 ANTIHISTAMINES 232
7.2.1.4.1 CETIRIZINE 232
7.2.1.4.2 BROMPHENIRAMINE 232
7.2.1.4.3 DIPHENHYDRAMINE 232
7.2.1.4.4 TERFENADINE 232
7.2.1.4.5 TRIMEPRAZINE 232
7.2.1.4.6 OTHERS 232
7.2.1.5 CORTICOSTEROIDS 233
7.2.1.5.1 DEXAMETHASONE 233
7.2.1.5.2 PREDNISOLONE 233
7.2.1.5.3 PREDNISONE 233
7.2.1.5.4 OTHERS 233
7.2.1.6 ANTIBLOAT 234
7.2.1.6.1 DOCUSATE 234
7.2.1.6.2 SIMETHICONE 234
7.2.1.6.3 OTHERS 234
7.2.1.7 HORMONAL 235
7.2.1.7.1 EQUINE CHORIONIC GONADOTROPIN 235
7.2.1.7.2 CLOPROSTENOL 235
7.2.1.7.3 OXYTOCIN 235
7.2.1.7.4 OTHERS 235
7.2.1.8 OPIOIDS 236
7.2.1.8.1 MU AGONISTS 236
7.2.1.8.1.1 METHADONE 237
7.2.1.8.1.2 MEPERIDINE 237
7.2.1.8.1.3 MORPHINE 237
7.2.1.8.1.4 OXYMORPHONE 237
7.2.1.8.1.5 OTHERS 237
7.2.1.8.2 PARTIAL MU AGONIST 238
7.2.1.8.2.1 BUPRENORPHINE 238
7.2.1.8.2.2 OTHERS 238
7.2.1.8.3 KAPPA AGONIST-MU ANTAGONIST 238
7.2.1.8.3.1 BUTORPHANOL 238
7.2.1.8.3.2 OTHERS 238
7.2.1.9 OTHERS 239
7.2.1.10 PHARMACEUTICALS BY DRUG TYPE 239
7.2.1.10.1 BRANDED 239
7.2.1.10.2 GENERIC 239
7.2.1.11 PHARMACEUTICALS BY PRESCRIPTION MODE 239
7.2.1.11.1 PRESCRIPTION BASED 239
7.2.1.11.2 OVER THE COUNTER 239
7.2.1.12 PHARMACEUTICALS BY ROUTE OF ADMINISTRATION, 240
7.2.1.12.1 ORAL 240
7.2.1.12.1.1 TABLETS 241
7.2.1.12.1.2 SOLUTIONS 241
7.2.1.12.1.3 POWDER 241
7.2.1.12.1.4 OTHERS 241
7.2.1.12.2 PARENTAL 241
7.2.1.12.2.1 INTRAVENOUS 241
7.2.1.12.2.2 SUBCUTANEOUS 241
7.2.1.12.2.3 OTHERS 241
7.2.1.12.3 TOPICAL 241
7.2.1.12.4 OTHERS 241
7.2.2 VACCINES 242
7.2.2.1 LIVE ATTENUATED VACCINES 242
7.2.2.2 TOXOID VACCINES 242
7.2.2.3 RECOMBINANT VACCINES 242
7.2.2.4 INACTIVATED VACCINES 242
7.2.2.5 OTHERS 242
7.2.3 BIOLOGICS 243
7.2.3.1 MARKETED 243
7.2.3.1.1 TOCERANIB 244
7.2.3.1.2 LOMUSTINE 244
7.2.3.1.3 CYCLOPHOSPHAMIDE 244
7.2.3.1.4 CHLORAMBUCIL 244
7.2.3.1.5 OTHERS 244
7.2.3.2 EMERGING 244
7.2.4 MEDICATED FEED ADDITIVES 245
7.2.4.1 ENZYMES 246
7.2.4.1.1 PHYTASE 247
7.2.4.1.2 CARBOHYDRASE 247
7.2.4.1.3 PROTEASE 247
7.2.4.1.4 AMYLASE 247
7.2.4.1.5 CELLULASE 247
7.2.4.1.6 MANNASE 247
7.2.4.1.7 GLUCANASE 247
7.2.4.1.8 XYLANASE 247
7.2.4.1.9 OTHERS 247
7.2.4.2 AMINO ACID 248
7.2.4.2.1 LYSINE 248
7.2.4.2.2 METHIONINE 248
7.2.4.2.3 THREONINE 248
7.2.4.2.4 TRYPTOPHAN 248
7.2.4.2.5 OTHERS 248
7.2.4.3 VITAMINS 249
7.2.4.3.1 FAT-SOLUBLE VITAMIN 249
7.2.4.3.1.1 VITAMIN A 250
7.2.4.3.1.2 VITAMIN E 250
7.2.4.3.1.3 VITAMIN D 250
7.2.4.3.1.4 VITAMIN K 250
7.2.4.3.2 WATER-SOLUBLE VITAMIN 250
7.2.4.3.2.1 VITAMIN B COMPLEX 250
7.2.4.3.2.2 VITAMIN C 250
7.2.4.4 ANTIOXIDANTS 251
7.2.4.4.1 BHA 251
7.2.4.4.2 BHT 251
7.2.4.4.3 ETHOXYQUIN 251
7.2.4.4.4 OTHERS 251
7.2.4.5 PROBIOTICS 252
7.2.4.6 LACTOBACILLI 252
7.2.4.7 BIFIDOBACTERIA 252
7.2.4.8 YEAST 252
7.2.4.9 STRETOCOCCUS THERMOPHILUS 252
7.2.4.10 FEED ACIDIFIERS 253
7.2.4.10.1 PROPIONIC ACID 253
7.2.4.10.2 FORMIC ACID 253
7.2.4.10.3 LACTIC ACID 253
7.2.4.10.4 CITRIC ACID 253
7.2.4.10.5 OTHERS 253
7.2.4.11 MYCOTOXIN DETOXIFIERS 254
7.2.4.11.1 MYCOTOXIN BINDERS 254
7.2.4.11.1.1 SILICATES 255
7.2.4.11.1.2 CLAYS 255
7.2.4.11.1.3 CHEMICAL POLYMERS 255
7.2.4.11.1.4 GLUCAN PRODUCTS 255
7.2.4.11.1.5 OTHERS 255
7.2.4.11.2 MYCOTOXIN MODIFIERS 255
7.2.4.12 PHYTOGENIC 256
7.2.4.12.1 ESSENTIAL OILS 256
7.2.4.12.2 HERBS & SPICES 256
7.2.4.12.3 OLEORESIN 256
7.2.4.12.4 OTHERS 256
7.2.4.13 CAROTENOIDS 257
7.2.4.13.1 BETA-CAROTENE 257
7.2.4.13.2 ASTAXANTHIN 257
7.2.4.13.3 LUTEIN 257
7.2.4.13.4 CANTHAXANTHIN 257
7.2.4.14 TRACE MINERALS 258
7.2.4.14.1 ZINC 258
7.2.4.14.2 COPPER 258
7.2.4.14.3 MANGANESE 258
7.2.4.14.4 IRON 258
7.2.4.14.5 SELENIUM 258
7.2.4.14.6 OTHERS 258
7.2.4.15 PRESERVATIVES 259
7.2.4.15.1 ANTICAKING AGENTS 259
7.2.4.15.2 MOLD INHIBITORS 259
7.2.4.16 FLAVOURS AND SWEETENERS 260
7.2.4.16.1 FLAVORS 260
7.2.4.16.2 SWEETENERS 260
7.2.4.16.2.1 SACCHARIN 261
7.2.4.16.2.2 NEOHESPERIDIN DIHYDROCHALCONE 261
7.2.4.16.2.3 GLYCYRRHIZIN 261
7.2.4.16.2.4 THAUMATIN 261
7.2.4.16.2.5 OTHERS 261
7.2.4.17 OTHERS 261
7.3 DIAGNOSTICS 262
7.3.1 INSTRUMENTS & DEVICES 263
7.3.1.1 IMAGING DEVICES 263
7.3.1.2 X-RAY IMAGING (RADIOGRAPHY) 264
7.3.1.2.1 SMALL ANIMALS 264
7.3.1.2.2 LARGE ANIMALS 264
7.3.1.3 ULTRASOUND 264
7.3.1.3.1 SMALL ANIMALS 264
7.3.1.3.2 LARGE ANIMALS 264
7.3.1.4 COMPUTED TOMOGRAPHY 265
7.3.1.4.1 SMALL ANIMALS 265
7.3.1.4.2 LARGE ANIMALS 265
7.3.1.5 MAGNETIC RESONANCE IMAGING 265
7.3.1.5.1 SMALL ANIMALS 265
7.3.1.5.2 LARGE ANIMALS 265
7.3.1.6 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 266
7.3.1.6.1 SMALL ANIMALS 266
7.3.1.6.2 LARGE ANIMALS 266
7.3.1.6.3 OTHERS 266
7.3.2 LABORATORY INSTRUMENTS 267
7.3.2.1 HEMATOLOGY ANALYZERS 268
7.3.2.1.1 BY MODE 268
7.3.2.1.1.1 AUTOMATIC 268
7.3.2.1.1.2 SEMI-AUTOMATIC 268
7.3.2.1.2 BY PRICE RANGE 268
7.3.2.1.2.1 HIGH PRICE RANGE 268
7.3.2.1.2.2 STANDARD PRICE RANGE 268
7.3.2.1.3 BY MODALITY, 269
7.3.2.1.3.1 BENCHTOP 269
7.3.2.1.3.2 PORTABLE 269
7.3.2.1.3.3 OTHERS 269
7.3.2.2 CHEMISTRY ANALYZERS 270
7.3.2.2.1 BY MODE 270
7.3.2.2.1.1 AUTOMATIC 270
7.3.2.2.1.2 SEMI-AUTOMATIC 270
7.3.2.2.2 BY MODALITY, 270
7.3.2.2.2.1 BENCHTOP 270
7.3.2.2.2.2 PORTABLE 270
7.3.2.2.3 BY SAMPLE TYPE, 271
7.3.2.2.3.1 BLOOD 271
7.3.2.2.3.2 URINE 271
7.3.2.2.3.3 STOOL 271
7.3.2.2.3.4 OTHERS 271
7.3.2.3 POINT-OF-CARE INSTRUMENTS 272
7.3.2.3.1 BY TYPE 272
7.3.2.3.1.1 LATERAL FLOW POCT 272
7.3.2.3.1.2 MOLECULAR POCT 272
7.3.2.3.1.3 OTHERS 272
7.3.2.3.2 BY MODE 273
7.3.2.3.2.1 AUTOMATIC 273
7.3.2.3.2.2 SEMI-AUTOMATIC 273
7.3.2.4 COAGULATION ANALYZERS 273
7.3.2.4.1 BY CHANNEL, 274
7.3.2.4.1.1.1 4-CHANNEL 274
7.3.2.4.1.1.2 1-CHANNEL 274
7.3.2.4.2 BY SAMPLE TYPE 274
7.3.2.4.2.1 WHOLE BLOOD 274
7.3.2.4.2.2 PLASMA 274
7.3.2.4.3 BY MODALITY, 275
7.3.2.4.3.1 BENCHTOP 275
7.3.2.4.3.2 PORTABLE 275
7.3.2.5 URINALYSIS EQUIPMENT 276
7.3.2.5.1 BY MODE 276
7.3.2.5.1.1 AUTOMATIC 276
7.3.2.5.1.2 SEMI-AUTOMATIC 276
7.3.2.6 REFRACTOMETER 276
7.3.2.6.1 BY MODE, 276
7.3.2.6.1.1 OPTICAL 277
7.3.2.6.1.2 DIGITAL 277
7.3.2.6.2 BY MODALITY, 277
7.3.2.6.2.1 BENCHTOP 277
7.3.2.6.2.2 PORTABLE 277
7.3.2.7 OTHERS 277
7.3.3 REAGENTS & CONSUMABLES 278
7.3.3.1 KITS 279
7.3.3.1.1 PCR KITS 279
7.3.3.1.2 RAPID TEST KITS 279
7.3.3.1.3 MULTIPLEX KITS 279
7.3.3.1.4 ELISA KITS 279
7.3.3.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS 279
7.3.3.1.6 OTHERS 279
7.3.3.2 REAGENTS 280
7.3.3.2.1 NUCLEIC ACID EXTRACTION REAGENTS 280
7.3.3.2.2 IMMUNOFLUORESCENCE REAGENTS 280
7.3.3.2.3 COOMBS REAGENTS 280
7.3.3.2.4 OTHERS REAGENTS 280
7.3.4 MEDIA 280
7.3.5 PANEL 280
7.3.6 STRIPS 280
7.3.7 CASSETTE 280
7.3.8 CONTROL STANDARDS 280
7.3.9 PROBES AND PRIMER 280
7.3.10 OTHERS CONSUMABLE AND ACCESSORIES 280
8 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY APPLICATION 281
8.1 OVERVIEW 282
8.2 BACTERIAL DISEASES 286
8.2.1 PRODUCTION ANIMALS 286
8.2.2 COMPANION ANIMALS 286
8.3 CANINE ATOPIC DERMATITIS 287
8.3.1 COMPANION ANIMALS 287
8.3.2 PRODUCTION ANIMALS 287
8.4 HEMINTHES INFECTION 288
8.4.1 PRODUCTION ANIMALS 288
8.4.2 COMPANION ANIMALS 288
8.5 ANIMAL CANCER 289
8.5.1 COMPANION ANIMALS 289
8.5.2 PRODUCTION ANIMALS 289
8.6 FOOT AND MOUTH DISEASE 290
8.6.1 PRODUCTION ANIMALS 290
8.6.2 COMPANION ANIMALS 290
8.7 AUTOIMMUNE DISEASES 291
8.7.1 COMPANION ANIMALS 291
8.7.2 PRODUCTION ANIMALS 291
8.8 BLUETONGUE 292
8.8.1 PRODUCTION ANIMALS 292
8.8.2 COMPANION ANIMALS 292
8.9 OTHERS 293
8.9.1 COMPANION ANIMALS 293
8.9.2 PRODUCTION ANIMAL 293
9 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE 294
9.1 OVERVIEW 295
9.2 COMPANION ANIMALS 298
9.2.1 DOGS 299
9.2.2 CATS 299
9.2.3 HORSES 299
9.2.4 OTHERS 299
9.3 PRODUCTION ANIMAL 300
9.3.1 POULTRY 301
9.3.2 CATTLE 301
9.3.3 SWINE 301
9.3.4 FISH 301
9.3.5 SHEEP & GOATS 301
9.3.6 OTHERS 301
10 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL 302
10.1 OVERVIEW 303
10.2 RETAIL SALES 306
10.2.1 OFFLINE 307
10.2.1.1 HOSPITAL PHARMACY 307
10.2.1.2 RETAIL PHARMACY 307
10.2.2 ONLINE 308
10.2.2.1 E-COMMERCE PLATFORMS 308
10.2.2.2 COMPANY WEBSITE 308
10.2.2.3 OTHERS 308
10.3 DIRECT TENDER 309
10.4 OTHERS 310
11 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY END USER 311
11.1 OVERVIEW 312
11.2 VETERINARY HOSPITALS 316
11.2.1 PRIVATE 316
11.2.2 PUBLIC 316
11.2.3 VETERINARY HOSPITALS BY LEVEL 317
11.2.3.1 TIER 2 317
11.2.3.2 TIER 1 317
11.2.3.3 TIER 3 317
11.3 VETERINARY CLINICS 318
11.3.1 VETERINARY CLINICS BY TYPE 318
11.3.1.1 PUBLIC 318
11.3.1.2 PRIVATE 318
11.4 ANIMAL AND VETERINARY FARMS 319
11.5 REFERENCE LABORATORIES 320
11.6 ACADEMIC AND RESEARCH INSTITUTE 321
11.7 POINT-OF-CARE TESTING/IN-HOUSE TESTING 322
11.8 OTHERS 323
12 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY REGION 324
12.1 MIDDLE EAST AND AFRICA 326
12.1.1 SOUTH AFRICA 356
12.1.2 SAUDI ARABIA 384
12.1.3 U.A.E 412
12.1.4 EGYPT 439
12.1.5 ISRAEL 466
12.1.6 REST OF MIDDLE EAST AND AFRICA 499
13 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE 501
13.1 COMPANY SHARE ANALYSIS: GLOBAL 501
14 SWOT ANALYSIS 502
15 COMPANY PROFILES 503
15.1 ZOETIS SERVICES LLC SERVICES LLC. 503
15.1.1 COMPANY SNAPSHOT 503
15.1.2 REVENUE ANALYSIS 504
15.1.3 COMPANY SHARE ANALYSIS 504
15.1.4 PRODUCT PORTFOLIO 504
15.1.5 RECENT DEVELOPMENT 505
15.2 MERCK KGAA 507
15.2.1 COMPANY SNAPSHOT 507
15.2.2 REVENUE ANALYIS 507
15.2.3 COMPANY SHARE ANALYSIS 508
15.2.4 PRODUCT PORTFOLIO 508
15.2.5 RECENT DEVELOPMENT 510
15.3 ELANCO OR ITS AFFILIATES. OR ITS AFFILIATES 511
15.3.1 COMPANY SNAPSHOT 511
15.3.2 REVENUE ANALYSIS 511
15.3.3 COMPANY SHARE ANALYSIS 512
15.3.4 PRODUCT PORTFOLIO 512
15.3.5 RECENT DEVELOPMENT 514
15.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 515
15.4.1 COMPANY SNAPSHOT 515
15.4.2 COMPANY SHARE ANALYSIS 515
15.4.3 PRODUCT PORTFOLIO 516
15.4.4 RECENT DEVELOPMENT 517
15.5 IDEXX LABORATORIES, INC 519
15.5.1 COMPANY SNAPSHOT 519
15.5.2 REVENUE ANALYSIS 519
15.5.3 COMPANY SHARE ANALYSIS 520
15.5.4 PRODUCT PORTFOLIO 520
15.5.5 RECENT DEVELOPMENT 522
15.6 AB SCIENCE 523
15.6.1 COMPANY SNAPSHOT 523
15.6.2 REVENUE ANALYSIS 523
15.6.3 PRODUCT PORTFOLIO 524
15.6.4 RECENT DEVELOPMENT 524
15.7 ADVACARE PHARMA 525
15.7.1 COMPANY SNAPSHOT 525
15.7.2 PRODUCT PORTFOLIO 525
15.7.3 RECENT DEVELOPMENT 526
15.8 ALMAX IMAGING SRL 527
15.8.1 COMPANY SNAPSHOT 527
15.8.2 PRODUCT PORTFOLIO 527
15.8.3 RECENT DEVELOPMENT 527
15.9 ANIVIVE 528
15.9.1 COMPANY SNAPSHOT 528
15.9.2 PRODUCT PORTFOLIO 528
15.9.3 RECENT DEVELOPMENT 531
15.10 BIOMÉRIEUX 532
15.10.1 COMPANY SNAPSHOT 532
15.10.2 REVENUE ANALYSIS 532
15.10.3 PRODUCT PORTFOLIO 533
15.10.4 RECENT DEVELOPMENT 533
15.11 BIONOTE USA INC. 534
15.11.1 COMPANY SNAPSHOT 534
15.11.2 PRODUCT PORTFOLIO 534
15.11.3 RECENT DEVELOPMENT 537
15.12 BIO-RAD LABORATORIES, INC. 538
15.12.1 COMPANY SNAPSHOT 538
15.12.2 REVENUE ANALYSIS 538
15.12.3 PRODUCT PORTFOLIO 539
15.12.4 RECENT DEVELOPMENT 541
15.13 CANON MEDICAL SYSTEMS EUROPE B.V. 542
15.13.1 COMPANY SNAPSHOT 542
15.13.2 REVENUE ANALYSIS 542
15.13.3 PRODUCT PORTFOLIO 543
15.13.4 RECENT DEVELOPMENT 543
15.14 CARGIL INCORPORATED 544
15.14.1 COMPANY SNAPSHOT 544
15.14.2 PRODUCT PORTFOLIO 544
15.14.3 RECENT DEVELOPMENT 546
15.15 CEVA 547
15.15.1 COMPANY SNAPSHOT 547
15.15.2 PRODUCT PORTFOLIO 547
15.15.3 RECENT DEVELOPMENT 549
15.16 CURELAB ONCOLOGY 550
15.16.1 COMPANY SNAPSHOT 550
15.16.2 PRODUCT PORTFOLIO 550
15.16.3 RECENT DEVELOPMENT 551
15.17 DECHRA PHARMACEUTICALS LIMITED 552
15.17.1 COMPANY SNAPSHOT 552
15.17.2 REVENUE ANALYSIS 552
15.17.3 PRODUCT PORTFOLIO 553
15.17.4 RECENT DEVELOPMENT 555
15.18 DEMEDITEC DIAGNOSTICS GMBH 556
15.18.1 COMPANY SNAPSHOT 556
15.18.2 PRODUCT PORTFOLIO 556
15.18.3 RECENT DEVELOPMENT 558
15.19 DHN 559
15.19.1 COMPANY SNAPSHOT 559
15.19.2 PRODUCT PORTFOLIO 559
15.19.3 RECENT DEVELOPMENT 561
15.20 DIAGNOSTIC IMAGING SYSTEMS 563
15.20.1 COMPANY SNAPSHOT 563
15.20.2 PRODUCT PORTFOLIO 563
15.20.3 RECENT DEVELOPMENT 565
15.21 ESAOTE SPA 566
15.21.1 COMPANY SNAPSHOT 566
15.21.2 PRODUCT PORTFOLIO 566
15.21.3 RECENT DEVELOPMENT 568
15.22 EUROFINS SCIENTIFIC 569
15.22.1 COMPANY SNAPSHOT 569
15.22.2 REVENUE ANALYSIS 570
15.22.3 PRODUCT PORTFOLIO 570
15.22.4 RECENT DEVELOPMENT 571
15.23 EVONIK ANIMAL NUTRITION 572
15.23.1 COMPANY SNAPSHOT 572
15.23.2 REVENUE ANALYSIS 572
15.23.3 1.1.3 PRODUCT PORTFOLIO 573
15.23.4 RECENT DEVELOPMENT 574
15.24 FUJIFILM HOLDINGS CORPORATION 575
15.24.1 COMPANY SNAPSHOT 575
15.24.2 REVENUE ANALYSIS 575
15.24.3 PRODUCT PORTFOLIO 576
15.24.4 RECENT DEVELOPMENT 579
15.25 GOLD STANDARD DIAGNOSTICS 580
15.25.1 COMPANY SNAPSHOT 580
15.25.2 PRODUCT PORTFOLIO 580
15.25.3 RECENT DEVELOPMENT 582
15.26 HALLMARQ VETERINARY IMAGING 583
15.26.1 COMPANY SNAPSHOT 583
15.26.2 PRODUCT PORTFOLIO 583
15.26.3 RECENT DEVELOPMENT 584
15.27 HEBEI VEYONG PHARMACEUTICAL CO., LTD. 585
15.27.1 COMPANY SNAPSHOT 585
15.27.2 PRODUCT PORTFOLIO 585
15.27.3 RECENT DEVELOPMENT 589
15.28 IBIS S.R.L. 590
15.28.1 COMPANY SNAPSHOT 590
15.28.2 PRODUCT PORTFOLIO 590
15.28.3 RECENT DEVELOPMENT 592
15.29 VIRBAC 593
15.29.1 COMPANY SNAPSHOT 593
15.29.2 REVENUE ANALYSIS 594
15.29.3 PRODUCT PORTFOLIO 594
15.29.4 RECENT DEVELOPMENT 597
15.30 VMRD, INC 598
15.30.1 COMPANY SNAPSHOT 598
15.30.2 PRODUCT PORTFOLIO 598
15.30.3 RECENT DEVELOPMENT 600
15.31 HESKA CORPORATION 601
15.31.1 COMPANY SNAPSHOT 601
15.31.2 REVENUE ANALYSIS 601
15.31.3 PRODUCT PORTFOLIO 602
15.31.4 RECENT DEVELOPMENT 603
15.32 KARYOPHARM 604
15.32.1 COMPANY SNAPSHOT 604
15.32.2 REVENUE ANALYSIS 604
15.32.3 PRODUCT PORTFOLIO 605
15.32.4 RECENT DEVELOPMENT 605
15.33 MERIDIAN BIOSCIENCE, INC 606
15.33.1 COMPANY SNAPSHOT 606
15.33.2 PRODUCT PORTFOLIO 606
15.33.3 RECENT DEVELOPMENT 607
15.34 NARANG MEDICAL LIMITED 608
15.34.1 COMPANY SNAPSHOT 608
15.34.2 PRODUCT PORTFOLIO 608
15.34.3 RECENT DEVELOPMENT 612
15.35 NEOGEN CORPORATION 613
15.35.1 COMPANY SNAPSHOT 613
15.35.2 REVENUE ANALYSIS 613
15.35.3 PRODUCT PORTFOLIO 614
15.35.4 RECENT DEVELOPMENT 616
15.36 NIPPON ZENYAKU KOGYO CO., LTD. 617
15.36.1 COMPANY SNAPSHOT 617
15.36.2 PRODUCT PORTFOLIO 617
15.36.3 RECENT DEVELOPMENT 618
15.37 VETDC 619
15.37.1 COMPANY SNAPSHOT 619
15.37.2 PRODUCT PORTFOLIO 619
15.37.3 RECENT DEVELOPMENT 620
15.38 NOVAVIVE INC. 621
15.38.1 COMPANY SNAPSHOT 621
15.38.2 PRODUCT PORTFOLIO 621
15.38.3 RECENT DEVELOPMENT 623
15.39 NUTRECO 624
15.39.1 COMPANY SNAPSHOT 624
15.39.2 PRODUCT PORTFOLIO 624
15.39.3 RECENT DEVELOPMENT 625
15.40 PLANMECA OY 626
15.40.1 COMPANY SNAPSHOT 626
15.40.2 PRODUCT PORTFOLIO 626
15.40.3 RECENT DEVELOPMENT 628
15.41 RANDOX LABORATORIES LTD. 629
15.41.1 COMPANY SNAPSHOT 629
15.41.2 PRODUCT PORTFOLIO 629
15.41.3 RECENT DEVELOPMENT 631
15.42 RINGPU BIOLOGY CO., LTD. 632
15.42.1 COMPANY SNAPSHOT 632
15.42.2 PRODUCT PORTFOLIO 632
15.42.3 RECENT DEVELOPMENT 635
15.43 SHENZHEN SONTU MEDICAL IMAGING EQUIPMENT CO., LTD 636
15.43.1 COMPANY SNAPSHOT 636
15.43.2 PRODUCT PORTFOLIO 636
15.43.3 RECENT DEVELOPMENT 638
15.44 THERMO FISHER SCIENTIFIC INC 639
15.44.1 COMPANY SNAPSHOT 639
15.44.2 REVENUE ANALYSIS 640
15.44.3 PRODUCT PORTFOLIO 640
15.44.4 RECENT DEVELOPMENT 641
15.45 TORIGEN PHARMACEUTICALS INC. 642
15.45.1 COMPANY SNAPSHOT 642
15.45.2 PRODUCT PORTFOLIO 642
15.45.3 RECENT DEVELOPMENT 643
16 QUESTIONNAIRE 644
17 RELATED REPORTS 647